Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence

Drug and Alcohol Dependence

Volumn 131, Issue 3, 2013, Pages 198-203

  van Wingen, Guido A ^a   van den Brink, Wim ^a   Veltman, Dick J ^a,b   Schmaal, Lianne ^a,b   Dom, Geert ^c   Booij, Jan ^a   Crunelle, Cleo L ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Attention deficit hyperactivity disorder; Cocaine; Grey matter volume; MRI; Putamen; Voxel based morphometry (VBM)

Indexed keywords

COCAINE;

ADULT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN REGION; BRAIN SIZE; CEREBELLUM; CLINICAL ARTICLE; COCAINE DEPENDENCE; COMORBIDITY; CONTROLLED STUDY; CORPUS STRIATUM; GRAY MATTER; HUMAN; IMAGING SOFTWARE; INTELLIGENCE; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PUTAMEN; VOXEL BASED MORPHOMETRY;

ATTENTION DEFICIT HYPERACTIVITY DISORDER; COCAINE; GREY MATTER VOLUME; MRI; PUTAMEN; VOXEL-BASED MORPHOMETRY (VBM);

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COCAINE-RELATED DISORDERS; COMORBIDITY; CORPUS STRIATUM; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; YOUNG ADULT;

EID: 84881237936     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.05.007     Document Type: Article

References (56)

1. Almeida Montes L.G., Ricardo-Garcell J., Barajas De La Torre L.B., Prado Alcántara H., Martínez García R.B., Fernández-Bouzas A., Avila Acosta D. Clinical correlations of grey matter reductions in the caudate nucleus of adults with attention deficit hyperactivity disorder. J. Psychiatry Neurosci. 2010, 35:238-246.
2. Amico F., Stauber J., Koutsouleris N., Frodl T. Anterior cingulate cortex gray matter abnormalities in adults with attention deficit hyperactivity disorder: a voxel-based morphometry study. Psychiatry Res. 2011, 191:31-35.
3. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
4. Beck A.T., Steer R.A. Manual for Revised Beck Depression Inventory 1987, Psychological Corporation, San Antonio, TX.
5. Berquin P.C., Giedd J.N., Jacobsen L.K., Hamburger S.D., Krain A.L., Rapoport J.L., Castellanos F.X. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 1998, 50:1087-1093.
6. Biederman J., Monuteaux M.C., Mick E., Spencer T., Wilens T.E., Silva J.M., Snyder L.E., Faraone S.V. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol. Med. 2006, 36:167-179.
7. Bora E., Fornito A., Pantelis C., Yücel M. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord. 2012, 138:9-18.
8. Brett M., Anton J.L., Valabregue R., Poline J.B. Region of Interest Analysis Using an SPM Toolbox [abstract]. Presented at the 8th International Conference on Functional Mapping of the Human Brain 2002, Available on CD-ROM in NeuroImage, vol. 16, No. 2.
9. Brieber S., Neufang S., Bruning N., Kamp-Becker I., Remschmidt H., Herpertz-Dahlmann B., Fink G.R., Konrad K. Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. J. Child Psychol. Psychiatry 2007, 48:1251-1258.
10. Carmona S., Vilarroya O., Bielsa A., Trèmols V., Soliva J.C., Rovira M., Tomàs J., Raheb C., Gispert J.D., Batlle S., Bulbena A. Global and regional gray matter reductions in ADHD: a voxel-based morphometric study. Neurosci. Lett. 2005, 389:88-93.
11. Carpentier P.J., de Jong C.A., Dijkstra B.A., Verbrugge C.A., Krabbe P.F. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 2005, 100:1868-1874.
12. Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Vaituzis A.C., Dickstein D.P., Sarfatti S.E., Vauss Y.C., Snell J.W., Lange N., Kaysen D., Krain A.L., Ritchie G.F., Rajapakse J.C., Rapoport J.L. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 1996, 53:607-616.
13. Castellanos F.X., Giedd J.N., Berquin P.C., Walter J.M., Sharp W., Tran T., Vaituzis A.C., Blumenthal J.D., Nelson J., Bastain T.M., Zijdenbos A., Evans A.C., Rapoport J.L. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 2001, 58:289-295.
14. Castellanos F.X., Lee P.P., Sharp W., Jeffries N.O., Greenstein D.K., Clasen L.S., Blumenthal J.D., James R.S., Ebens C.L., Walter J.M., Zijdenbos A., Evans A.C., Giedd J.N., Rapoport J.L. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002, 288:1740-1748.
15. Conners C.K., Erhardt D., Sparrow E. Conners' Adult ADHD Rating Scales 1999, Multi-Health Systems, North Tonawanda.
16. Crunelle C.L., Miller M.L., Booij J., van den Brink W. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. Eur. Neuropsychopharmacol. 2010, 20:69-79.
17. Crunelle C.L., Schulz S., de Bruin K., Miller M.L., van den Brink W., Booij J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. Eur. Neuropsychopharmacol. 2011, 21:205-210.
18. Crunelle C.L., Veltman D.J., van Emmerik-van Oortmerssen K., Booij J., van den Brink W. Impulsivity in adult ADHD patients with and without cocaine dependence. Drug Alcohol Depend. 2012, 129:18-24.
19. Depue B.E., Burgess G.C., Bidwell L.C., Willcutt E.G., Banich M.T. Behavioral performance predicts grey matter reductions in the right inferior frontal gyrus in young adults with combined type ADHD. Psychiatry Res. 2010, 182:231-237.
20. Fein G., Di Sclafani V., Meyerhoff D.J. Prefrontal cortical volume reduction associated with frontal cortex function deficit in 6-week abstinent crack-cocaine dependent men. Drug Alcohol Depend. 2002, 68:87-93.
21. Frodl T., Skokauskas N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta. Psychiatr. Scand. 2012, 125:114-126.
22. Hayasaka S., Phan K.L., Liberzon I., Worsley K.J., Nichols T.E. Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 2004, 22:676-687.
23. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerström K.O. The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br. J. Addict. 1991, 86:1119-1127.
24. Kobel M., Bechtel N., Specht K., Klarhöfer M., Weber P., Scheffler K., Opwis K., Penner I.K. Structural and functional imaging approaches in attention deficit/hyperactivity disorder: does the temporal lobe play a key role?. Psychiatry Res. 2010, 183:230-236.
25. Konstenius M., Jayaram-Lindström N., Beck O., Franck J. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend. 2010, 108:130-133.
26. Kooij J.J., Buitelaar J.K., van den Oord E.J., Furer J.W., Rijnders C.A., Hodiamont P.P. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol. Med. 2005, 35:817-827.
27. Kühn S., Romanowski A., Schilling C., Mobascher A., Warbrick T., Winterer G., Gallinat J. Brain grey matter deficits in smokers: focus on the cerebellum. Brain Struct. Funct. 2011, 217:517-522.
28. Lee S.S. Childhood ADHD increases the risk of nicotine use in adolescence and alcohol use in young adulthood. Evid. Based Ment. Health 2011, 14:63.
29. Levin F.R., Evans S.M., McDowell D.M., Kleber H.D. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J. Clin. Psychiatry 1998, 59:300-305.
30. Levin F.R., Evans S.M., Brooks D.J., Kalbag A.S., Garawi F., Nunes E.V. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend. 2006, 81:137-148.
31. Levin F.R., Evans S.M., Brooks D.J., Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend. 2007, 87:20-29.
32. Ludolph A.G., Kassubek J., Schmeck K., Glaser C., Wunderlich A., Buck A.K., Reske S.N., Fegert J.M., Mottaghy F.M. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study. Neuroimage 2008, 41:718-727.
33. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003, 19:1233-1239.
34. Maldjian J.A., Laurienti P.J., Burdette J.H. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004, 21:450-455.
35. Max J.E., Fox P.T., Lancaster J.L., Kochunov P., Mathews K., Manes F.F., Robertson B.A., Arndt S., Robin D.A., Lansing A.E. Putamen lesions and the development of attention-deficit/hyperactivity symptomatology. J. Am. Acad. Child Adolesc. Psychiatry 2002, 41:563-571.
36. Max J.E., Manes F.F., Robertson B.A., Mathews K., Fox P.T., Lancaster J. Prefrontal and executive attention network lesions and the development of attention-deficit/hyperactivity symptomatology. J. Am. Acad. Child Adolesc. Psychiatry 2005, 44:443-450.
37. McAlonan G.M., Cheung V., Cheung C., Chua S.E., Murphy D.G., Suckling J., Tai K.S., Yip L.K., Leung P., Ho T.P. Mapping brain structure in attention deficit-hyperactivity disorder: a voxel-based MRI study of regional grey and white matter volume. Psychiatry Res. 2007, 154:171-180.
38. Moreno-López L., Catena A., Fernández-Serrano M.J., Delgado-Rico E., Stamatakis E.A., Pérez-García M., Verdejo-García A. Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Drug Alcohol Depend. 2012, 125:208-214.
39. Narayana P.A., Datta S., Tao G., Steinberg J.L., Moeller F.G. Effect of cocaine on structural changes in brain: MRI volumetry using tensor-based morphometry. Drug Alcohol Depend. 2010, 111:191-199.
40. Overmeyer S., Bullmore E.T., Suckling J., Simmons A., Williams S.C., Santosh P.J., Taylor E. Distributed grey and white matter deficits in hyperkinetic disorder: MRI evidence for anatomical abnormality in an attentional network. Psychol. Med. 2001, 31:1425-1435.
41. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. J. Clin. Psychol. 1995, 51:768-774.
42. Rando K., Tuit K., Hannestad J., Guarnaccia J., Sinha R. Sex differences in decreased limbic and cortical grey matter volume in cocaine dependence: a voxel-based morphometric study. Addict. Biol. 2013, 18:147-160.
43. Schmand B., Bakker D., Saan R., Louman J. The Dutch reading test for adults: a measure of premorbid intelligence level. Tijdschr. Gerontol. Geriatr. 1991, 22:15-19.
44. Schubiner H., Saules K.K., Arfken C.L., Johanson C.E., Schuster C.R., Lockhart N., Edwards A., Donlin J., Pihlgren E. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp. Clin. Psychopharmacol. 2002, 10:286-294.
45. Seidman L.J., Biederman J., Liang L., Valera E.M., Monuteaux M.C., Brown A., Kaiser J., Spencer T., Faraone S.V., Makris N. Grey matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol. Psychiatry 2011, 69:857-866.
46. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:22-33.
47. Sim M.E., Lyoo I.K., Streeter C.C., Covell J., Sarid-Segal O., Ciraulo D.A., Kim M.J., Kaufman M.J., Yurgelun-Todd D.A., Renshaw P.F. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology 2007, 32:2229-2237.
48. Somoza E.C., Winhusen T.M., Bridge T.P., Rotrosen J.P., Vanderburg D.G., Harrer J.M., Mezinskis J.P., Montgomery M.A., Ciraulo D.A., Wulsin L.R., Barrett J.A. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J. Addict. Dis. 2004, 23:77-92.
49. Szobot C.M., Rohde L.A., Katz B., Ruaro P., Schaefer T., Walcher M., Bukstein O., Pechansky F. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder. Braz. J. Med. Biol. Res. 2008, 41:250-257.
50. Tanabe J., Tregellas J.R., Dalwani M., Thompson L., Owens E., Crowley T., Banich M. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol. Psychiatry 2009, 65:160-164.
51. Upadhyaya H.P., Carpenter M.J. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use?. Am. J. Addict. 2008, 17:195-198.
52. van Emmerik-van Oortmerssen K., van de Glind G., van den Brink W., Smit F., Crunelle C.L., Swets M., Schoevers R.A. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012, 122:11-19.
53. Volkow N.D., Wang G.J., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F., Fowler J.S., Zhu W., Logan J., Ma Y., Pradhan K., Wong C., Swanson J.M. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 2009, 302:1084-1091.
54. Wilens T.E., Adler L.A., Weiss M.D., Michelson D., Ramsey J.L., Moore R.J., Renard D., Brady K.T., Trzepacz P.T., Schuh L.M., Ahrbecker L.M., Levine L.R. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008, 96:145-154.
55. Yang P., Wang P.N., Chuang K.H., Jong Y.J., Chao T.C., Wu M.T. Absence of gender effect on children with attention-deficit/hyperactivity disorder as assessed by optimized voxel-based morphometry. Psychiatry Res. 2008, 164:245-253.
56. Zhang X., Salmeron B.J., Ross T.J., Geng X., Yang Y., Stein E.A. Factors underlying prefrontal and insula structural alterations in smokers. Neuroimage 2011, 54:42-48.